Table 3. Number and proportion of rats with positive microbiological growth for strains of extended-spectrum beta-lactamase producing E. coli in organs and tissues.
Organ/Tissue | Groups | ||||
I | II | III | IV | P | |
n = 15 | n = 15 | n = 8 | n = 8 | ||
Lung | 10 (67%) | 9 (60%) | 6 (75%) | 1 (13%) | 0.04 * |
Spleen | 3 (20%) | 3 (20%) | 2 (25%) | 0 | 0.54 |
Liver | 8 (53%) | 8 (53%) | 6 (75%) | 3 (38%) | 0.51 |
Portal Blood | 2/12 (17%) | 1 (6%) | 0/7 | 1 (13%) | 0.64 |
Systemic Blood | 3/12 (25%) | 1 (6%) | 1/7 (14%) | 0 | 0.32 |
Mesenteric lymph nodes | 7 (47%) | 3 (20%) | 4 (50%) | 1 (13%) | 0.17 |
Cervical lymph nodes | 3 (20%) | 4 (27%) | 1 (13%) | 1 (13%) | 0.80 |
I - surgical group with hepatic ischemia and intestinal stasis; II - surgical group with hepatic ischemia without intestinal stasis; III - surgical control group; IV - non-surgical control group.
*Fisher’s test comparing groups: I and IV p:0.02; II and IV p:0.04; III and IV p:0.02.